HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.

Abstract
Protein kinase CK2 is implicated in the regulation of the cell cycle. In addition to a variety of functions, CK2 has anti-apoptotic properties. So far the role of CK2 linking both pathways in the cell is not clear. Some years ago we found that CK2 phosphorylates cdc25C, one member of the cdc25 family of proteins. In this study, we showed that inhibition of CK2 activity by three different inhibitors led to a down-regulation of the level of cdc25C. Inhibition of CK2 activity by transfecting the dominant-negative CK2α subunit also resulted in a down-regulation of the level of cdc25C whereas inhibition of CK2α' had no effect on the cdc25C level. In both cases, we observed apoptosis by PARP cleavage as well as by an increase in γH2AX phosphorylation. These results show that down-regulation of the level of cdc25C is not a prerequisite for the induction of apoptosis.
AuthorsCarolin C Schneider, Claudia Götz, Andrea Hessenauer, Jürgen Günther, Sabine Kartarius, Mathias Montenarh
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 356 Issue 1-2 Pg. 177-84 (Oct 2011) ISSN: 1573-4919 [Electronic] Netherlands
PMID21750987 (Publication Type: Journal Article)
Chemical References
  • 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole
  • 4,5,6,7-tetrabromobenzotriazole
  • Anthraquinones
  • Benzimidazoles
  • Mutant Proteins
  • Protein Kinase Inhibitors
  • Triazoles
  • 1,2,5,8-tetrahydroxy anthraquinone
  • Casein Kinase II
  • CDC2 Protein Kinase
  • cdc25 Phosphatases
Topics
  • Anthraquinones (pharmacology)
  • Apoptosis (drug effects)
  • Benzimidazoles (pharmacology)
  • CDC2 Protein Kinase (metabolism)
  • Casein Kinase II (antagonists & inhibitors, metabolism)
  • Cell Line, Tumor
  • Down-Regulation (drug effects)
  • Genes, Dominant (genetics)
  • Humans
  • Male
  • Mutant Proteins (metabolism)
  • Prostatic Neoplasms (enzymology, pathology)
  • Protein Kinase Inhibitors (pharmacology)
  • Transfection
  • Triazoles (pharmacology)
  • cdc25 Phosphatases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: